The proportions of patients who achieved HbA1c < 8.0 , < 7.0 and < 6.0 % at week 12 were significantly higher in alogliptin and insulin group ( 73.0 , 23.3 and 1.1 % ) than in placebo and insulin group ( 25.0 , 5.7 and 0 % ) .